Factors Associated with Initial or Subsequent Choice of Biologic Disease Modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis

被引：0
|
作者：
Jin, Yinzhu [1 ]
Desai, Rishi J. [1 ]
Liu, Jun [1 ]
Choi, Nam-Kyong [1 ]
Kim, Seoyoung [1 ,2 ,3 ]
机构：
[1] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[3] Harvard Med Sch, Boston, MA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
基金：
新加坡国家研究基金会;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3094
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritis
    Yinzhu Jin
    Rishi J. Desai
    Jun Liu
    Nam-Kyong Choi
    Seoyoung C. Kim
    Arthritis Research & Therapy, 19
  • [2] Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritis
    Jin, Yinzhu
    Desai, Rishi J.
    Liu, Jun
    Choi, Nam-Kyong
    Kim, Seoyoung C.
    ARTHRITIS RESEARCH & THERAPY, 2017, 19
  • [3] Factors Associated with the Use of Biologic Disease-modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis
    Hosseini, Roya
    Fawaz, Souhiela
    Seoane-Vazquez, Enrique
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2595 - 2595
  • [4] FACTORS ASSOCIATED WITH BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS UTILIZATION IN RHEUMATOID ARTHRITIS PATIENTS
    Hosseini, R.
    Brown, L.
    Rodriguez-Monguio, R.
    Seoane-Vazquez, E.
    VALUE IN HEALTH, 2022, 25 (07) : S453 - S453
  • [5] FACTORS ASSOCIATED WITH INITIATION OF BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN MOROCCAN PATIENTS WITH RHEUMATOID ARTHRITIS
    Hammou, O.
    Chennouf, F.
    Azzouzi, H.
    Linda, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1441 - 1441
  • [6] ANNUAL TREATMENT COST OF BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS
    Hosseini, R.
    Brown, L. M.
    Fleming, M.
    Rodriguez-Monguio, R.
    Seoane-Vazquez, E.
    VALUE IN HEALTH, 2024, 27 (06) : S110 - S110
  • [7] TREATMENT ADHERENCE TO CONVENTIONAL AND BIOLOGIC DISEASE MODIFYING ANTIRHEUMATIC DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Feldman, C. H.
    Lii, J.
    Gopalakrishnan, C.
    Franklin, J. M.
    Kim, S. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 526 - 526
  • [8] Factors Associated with the Initiation of Biologic Disease-Modifying Antirheumatic Drugs in Texas Medicaid Patients with Rheumatoid Arthritis
    Kim, Gilwan
    Barner, Jamie C.
    Rascati, Karen
    Richards, Kristin
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2015, 21 (05): : 401 - 407
  • [9] FACTORS ASOCIATED WITH THE INITIATION OF BIOLOGIC DISEASE MODIFYING ANTIRHEUMATIC DRUGS IN TEXAS MEDICAID PATIENTS WITH RHEUMATOID ARTHRITIS
    Kim, G.
    Barner, J. C.
    Rascati, K. L.
    Richards, K. M.
    VALUE IN HEALTH, 2014, 17 (03) : A42 - A42
  • [10] Mixed Treatment Comparison of the Treatment Discontinuations of Biologic Disease-Modifying Antirheumatic Drugs in Adults with Rheumatoid Arthritis
    Desai, Rishi J.
    Hansen, Richard A.
    Rao, Jaya K.
    Wilkins, Tania M.
    Harden, Elizabeth A.
    Yuen, Andrea
    Jonas, Daniel E.
    Roubey, Robert
    Jonas, Beth
    Gartlehner, Gerald
    Lux, Linda
    Donahue, Katrina E.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (11) : 1491 - 1505
12345